Morgan Urello

Title: Morgan Urello: Innovator in Nucleic Acid Delivery Systems

Introduction

Morgan Urello is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid delivery systems. His innovative work focuses on enhancing the efficiency of delivering polynucleotides into cells, which has important implications for medical treatments and therapies.

Latest Patents

Morgan Urello holds a patent for a composition that facilitates the delivery of polynucleotides into cells via a polyplex. The patent, titled "Collagen-mimetic peptide mediated delivery of nucleic acid carriers for efficient delivery from collagen," describes a polyplex that includes a polynucleotide and a polymer. The composition also features a collagen-mimetic peptide (CMP) and collagen fragments, which are bound to the polyplex. This invention has various applications, including methods for improving wound healing, enhancing cell proliferation, and promoting cell migration.

Career Highlights

Morgan Urello is affiliated with the University of Delaware, where he continues to advance research in his field. His work has garnered attention for its potential to revolutionize how nucleic acids are delivered in therapeutic contexts. With a focus on practical applications, Urello's research aims to address critical challenges in biotechnology.

Collaborations

Morgan collaborates with notable colleagues such as Kristi Kiick and Millicent Sullivan. These partnerships enhance the scope and impact of his research, fostering innovation in the field of biotechnology.

Conclusion

Morgan Urello is a key figure in the development of advanced nucleic acid delivery systems. His patent and ongoing research contribute significantly to the field, paving the way for future innovations in medical treatments.